Skip to content

Clinical trials

Phase 1 Neuroblastoma trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuroblastoma Phase: Phase 1 Country / region: China Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20151
20161
20211
20243
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting7
Completed1
Not yet recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sichuan University2
Sun Yat-sen University2
Chinese PLA General Hospital1
Nanjing Children's Hospital1
Peking Union Medical College Hospital1
Pfizer1
Shenzhen Second People's Hospital1
The General Hospital of Western Theater Command1
Zhujiang Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuroblastoma11
Recurrence3
Breast Neoplasms1
Esophageal Neoplasms1
Lung Neoplasms1
Lymphoma1
Medulloblastoma1
Melanoma1
Multiple Myeloma1
Nasopharyngeal Carcinoma1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.